BIOPHARMA CREDIT USD
SELL
83.4p
BUY
83.4p
CHARGE PER TRADE
£4.95
TODAY'S CHANGE
0.00%
OCF
1.13%
YIELD
8.5%
1 YEAR
-12.08%Prices as at 07 Dec 2023.
We don’t currently provide commentary on this fund.
Past performance is not an indication of future performance.
Capital at risk.
To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The Company will seek to achieve its investment objective predominantly through direct or indirect exposure to Debt Assets, which include Royalty Investments, Senior Secured Debt, Unsecured Debt and Credit Linked Notes.
Fund summary
| Sector | Debt - Direct Lending |
|---|---|
| Structure | INVESTMENT TRUST |
| Launched | March 2017 |
| Size | £887m |
| Yield | 8.5% |
| Dividends paid | March, April, August, October |
Charges
| Annual Management Charge | 1% |
|---|---|
| Ongoing Charges Figure | 1.13% |
Investment Process
The information on this website is not intended to be advice or a recommendation to buy, sell or hold any investment mentioned. The value of investments and the income from them can go down as well as up and you may not get back the amount invested.
Past performance is not a guide to future performance. View full risk warning